AS

Anwer Saeeda

Active Director Director DIN 00624252
DIN 00624252 First appointment Jan 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 1992
Shareholding value •••• Premium profile

About Anwer Saeeda

Data last updated:

Anwer Saeeda is a Director at Lorda Pharmaceuticals Private Limited (since 1992). The company operates in Pharma. Lorda Pharmaceuticals Private Limited reported revenue of ₹94,569 (FY 2016).

DIN 00624252
Primary Designation Director
Industry Pharma
First Appointment 01 Jan 1992
Oldest Company Age 34 yrs
Largest company Lorda Pharmaceuticals Private Limited · ₹94,569 (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 19921992₹94,569 (FY 2016)Active

Board colleagues of Anwer Saeeda

Directorship timeline

Open interactive timeline →
Lorda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anwer Saeeda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anwer Saeeda

Anwer Saeeda currently holds 1 directorship: Lorda Pharmaceuticals Private Limited (Director, since 01 Jan 1992, revenue ₹94,569 (FY 2016)).

Anwer Saeeda was first appointed on 01 Jan 1992 as Director at Lorda Pharmaceuticals Private Limited.

The current boards of Anwer Saeeda's companies include Barirah Ahmad (Lorda Pharmaceuticals Private Limited), Makeen Ahmad (Lorda Pharmaceuticals Private Limited), Raihan Saeeda (Lorda Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available